International Journal of Legal Medicine · 2021 · 49 citations · 9 references
Life SciencesInfectious DiseasesMicrobiologyMedical MicrobiologyMolecular VirologyVirologyRespiratory DiseaseRespiratory InfectionsRespiratory Infectious DiseasesViral EpidemiologyViral InfectionsViral PersistenceReal-time Polymerase Chain Reaction (Pcr)Real-time Polymerase Chain Reaction AssaysReverse Transcription Polymerase Chain Reaction (Rt-pcr)Sars-cov-2 InfectionSevere Acute Respiratory Syndrome
The duration of infectivity of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) in living patients has been demarcated. In contrast, a possible SARS-CoV-2 infectivity of corpses and subsequently its duration under post mortem circumstances remain to be elucidated. The aim of this study was to investigate the infectivity and its duration of deceased COVID-19 (coronavirus disease) patients. Four SARS-CoV-2 infected deceased patients were subjected to medicolegal autopsy. Post mortem intervals (PMI) of 1, 4, 9 and 17 days, respectively, were documented. During autopsy, swabs and organ samples were taken and examined by RT-qPCR (real-time reverse transcription-polymerase chain reaction) for the detection of SARS-CoV-2 ribonucleic acid (RNA). Determination of infectivity was performed by means of virus isolation in cell culture. In two cases, virus isolation was successful for swabs and tissue samples of the respiratory tract (PMI 4 and 17 days). The two infectious cases showed a shorter duration of COVID-19 until death than the two non-infectious cases (2 and 11 days, respectively, compared to > 19 days), which correlates with studies of living patients, in which infectivity could be narrowed to about 6 days before to 12 days after symptom onset. Most notably, infectivity was still present in one of the COVID-19 corpses after a post-mortem interval of 17 days and despite already visible signs of decomposition. To prevent SARS-CoV-2 infections in all professional groups involved in the handling and examination of COVID-19 corpses, adequate personal safety standards (reducing or avoiding aerosol formation and wearing FFP3 [filtering face piece class 3] masks) have to be enforced for routine procedures.
9
Virological assessment of hospitalized patients with COVID-2019
Roman Wölfel, Victor M. Corman, Wolfgang Guggemos et al. · Nature · 2020 · 7.2K citations · Full text
Chih‐Cheng Lai, Tzu-Ping Shih, Wen‐Chien Ko et al. · International Journal of Antimicrobial Agents · 2020 · 6.4K citations · Full text
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +12
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
Dominic Wichmann, Jan‐Peter Sperhake, Marc Lütgehetmann et al. · Annals of Internal Medicine · 2020 · 2.4K citations · Full text
Anika Singanayagam, Monika Patel, André Charlett et al. · Eurosurveillance · 2020 · 988 citations · Full text
Veterinary Medicine, Infectious Diseases, Infectious Disease Epidemiology +16